365 related articles for article (PubMed ID: 16640168)
1. Calcium channel blockers in hypertension. Is there still a controversy?
Izzo JL
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):1-5. PubMed ID: 16640168
[TBL] [Abstract][Full Text] [Related]
2. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
3. Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America.
Alcocer L; Bendersky M; Acosta J; Urina-Triana M
Am J Cardiovasc Drugs; 2010; 10(3):143-54. PubMed ID: 20524716
[TBL] [Abstract][Full Text] [Related]
4. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
5. Which drug should be used to treat patients with uncomplicated essential hypertension?
Rashidi A; Rahman M; Wright JT
Curr Opin Nephrol Hypertens; 2006 May; 15(3):303-8. PubMed ID: 16609299
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers and stroke.
Inzitari D; Poggesi A
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
[TBL] [Abstract][Full Text] [Related]
7. Use of calcium channel blockers in hypertension.
Conlin PR; Williams GH
Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
[TBL] [Abstract][Full Text] [Related]
8. [Differential therapy with calcium antagonists].
Scholze JE
Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
[TBL] [Abstract][Full Text] [Related]
9. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers in cardiovascular pharmacotherapy.
Godfraind T
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
[TBL] [Abstract][Full Text] [Related]
12. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers.
Papadopoulos DP; Papademetriou V
J Hypertens; 2008 May; 26(5):844-52. PubMed ID: 18398322
[TBL] [Abstract][Full Text] [Related]
13. A review of stroke in patients with hypertension and coronary artery disease: Focus on calcium channel blockers.
Bangalore S; Messerli FH
Int J Clin Pract; 2006 Oct; 60(10):1281-6. PubMed ID: 16942591
[TBL] [Abstract][Full Text] [Related]
14. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
15. Hypertension, possible vascular protection and lercanidipine.
Ram CV
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):783-8. PubMed ID: 17173495
[TBL] [Abstract][Full Text] [Related]
16. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
Ferri C; Croce G; Desideri G
Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive drugs and the sympathetic nervous system.
Del Colle S; Morello F; Rabbia F; Milan A; Naso D; Puglisi E; Mulatero P; Veglio F
J Cardiovasc Pharmacol; 2007 Nov; 50(5):487-96. PubMed ID: 18030057
[TBL] [Abstract][Full Text] [Related]
19. Systolic hypertension.
Nash DT
Geriatrics; 2006 Dec; 61(12):22-8. PubMed ID: 17184139
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel blockers and coronary heart disease.
Inzitari M; Di Bari M; Marchionni N
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
